ClinicalTrials.Veeva

Menu
L

Luzerner Kantonsspital | Luzern - Cardiology Department

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

DAPT
Ibrutinib
Cisplatin
Carboplatin
Ipilimumab
PLD
Gemcitabine
Doxorubicin
Rovalpituzumab
Atezolizumab

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

7 of 88 total trials

(HARBOR) Study to Evaluate Efficacy and Safety of BLU-263 Versus Placebo in Patients With Indolent Systemic Mastocytosis

This is a randomized, double-blind, placebo-controlled, Phase 2/3 study comparing the efficacy and safety of elenestinib (BLU-263) + best supportive...

Enrolling
Monoclonal Mast Cell Activation Syndrome
Smoldering Systemic Mastocytosis
Drug: Placebo
Drug: Elenestinib

This study is a prospective, multicenter, randomized controlled trial of an interventional strategy using the ClotTriever System to achieve and maint...

Enrolling
Venous Thromboembolism
Deep Venous Thrombosis
Device: ClotTriever System
Drug: Commercially available/market approved anticoagulation medication including but not limited to: Heparin Sodium, Coumadin, Rivaroxaban, Apixaban, etc.

The purpose of this trial is to generate clinical evidence related to key performance outcomes of Endurant II/IIs Stent Graft Systems verses Gore Exc...

Enrolling
Abdominal Aortic Aneurysm >= 5.0 Centimeters in Female (Disorder)
Abdominal Aortic Aneurysm
Device: Gore Excluder or Gore/ Excluder Conformable AAA Endoprosthesis
Device: Medtronic Endurant II or Endurant IIs Stent Graft System

The purpose of this study is to assess if using the Impella® CP (or Impella® 2.5) device during high-risk PCI in patients with reduced left-sided hea...

Enrolling
Coronary Artery Disease
Left Ventricular Dysfunction
Device: Impella CP® / Impella CP® with SmartAssist® / Impella 2.5®
Device: IABP Intra-aortic balloon pump

The purpose of this study is to evaluate the efficacy of addition of letrozole to the standard maintenance therapy in subjects following a primary di...

Enrolling
High-grade Serous Ovarian Carcinoma (HGSOC)
Fallopian Tube Neoplasms
Other: Placebo
Drug: Letrozole 2.5mg

POLAR is a phase III clinical trial, which will test the safety and efficacy of an investigational combination of drugs to learn whether the combinat...

Enrolling
Breast Cancer Recurrent
Drug: Standard endocrine therapy
Drug: Palbociclib 125mg

This study is a prospective, multicenter, randomized controlled trial of the FlowTriever System plus anticoagulation compared to anticoagulation alon...

Enrolling
Pulmonary Embolism
Drug: Anticoagulation Agents
Device: FlowTriever System

Trial sponsors

S
L
I
Abbott logo
University Hospital Basel logo
A
A
AbbVie logo
Bayer logo
B

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems